SPI1 and Alzheimer disease: Conversely, lower PU.1 expression increases microglial susceptibility to cytotoxicity, dampens inflammatory cascades, and reduces A1 astrocyte signatures, consistent with the protective effect of certain SPI1 genotypes in AD [44].